AQR Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

AQR Capital Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-21,358	Closed	-$976K	–	2333
2017 Q4	$976K	Sell	21,358 -12,122	-36%	-$605K	﹤0.01%	1685
2017 Q3	$1.5M	Sell	33,480 -68,318	-67%	-$2.33M	﹤0.01%	1502
2017 Q2	$3.04M	Buy	+101,798	New	+$2.51M	﹤0.01%	1221
2017 Q1	–	Sell	-199,463	Closed	-$3.76M	–	2299
2016 Q4	$3.76M	Sell	199,463 -178,324	-47%	-$4.36M	0.01%	1150
2016 Q3	$11.3M	Buy	377,787 +145,355	+63%	+$4.52M	0.02%	721
2016 Q2	$8.94M	Buy	232,432 +199,147	+598%	+$8.27M	0.02%	744
2016 Q1	$1.27M	Buy	+33,285	New	+$1.16M	﹤0.01%	1485
2015 Q3	–	Sell	-7,200	Closed	-$384K	–	2323
2015 Q2	$384K	Buy	+7,200	New	+$382K	﹤0.01%	1886

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

AQR Capital Management's JUNO Position: Q1 2018 in Review

AQR Capital Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 21,358 shares — an estimated $976K sold.

AQR Capital Management first reported a position in JUNO in Q2 2015 and held it in 8 quarters. The position peaked at $11.3M in Q3 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

AQR Capital Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
AQR Capital Management sold 21,358 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $976K.
AQR Capital Management first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 8 quarters.
AQR Capital Management's Juno Therapeutics, Inc. position peaked at $11.3M in Q3 2016.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on AQR Capital Management's 13F filing for Q1 2018, filed 15 May 2018.